{"id":61096,"date":"2025-04-15T19:05:12","date_gmt":"2025-04-15T17:05:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/"},"modified":"2025-04-15T19:05:12","modified_gmt":"2025-04-15T17:05:12","slug":"wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/","title":{"rendered":"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Unsecured creditors encouraged to vote in favor of the Amended Plan<\/i>\n<\/p>\n<p class=\"bwalignc\">\n<i>Confirmation hearing scheduled for April 30<\/i>\n<\/p>\n<p>NASHVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;Wellpath and certain of its affiliates (\u201cWellpath\u201d or the \u201cCompany\u201d), the nation\u2019s leader in providing compassionate medical healthcare to vulnerable patients in challenging clinical environments, announced today that it has reached a global settlement with the Statutory Unsecured Claimholders\u2019 Committee (the \u201cCommittee\u201d or \u201cUCC\u201d) and its Ad Hoc Lender Group on a consensual Plan of Reorganization (the \u201cPlan\u201d).\n<\/p>\n<p>\nFollowing productive engagement with the Ad Hoc Lender Group and the Committee, Wellpath will file an amended Plan consistent with the global settlement. The agreement and amended Plan resolve the Committee\u2019s opposition to the Plan and pending settlement between Wellpath and its existing financial sponsor. Accordingly, the Committee is now encouraging all general unsecured creditors to vote in favor of the amended plan ahead of the April 22, 2025 voting deadline.\n<\/p>\n<p>\n\u201cWe have worked extensively alongside our lenders and the Committee to develop a Plan that provides the best outcome for all stakeholders,\u201d said Ben Slocum, Chief Executive Officer of Wellpath. \u201cWe are grateful to the parties for their cooperation, which has allowed us to reach this milestone and move forward. We are nearing the finish line and look forward to emerging from this process in the best position possible to fulfill our mission. As we take these final steps, we will continue prioritizing our clients and patients, as we meet our obligations to our partners and continue to put patient care first.\u201d\n<\/p>\n<p>\nThe settlement clears the path for Wellpath\u2019s amended Plan to be heard by the Court at the Confirmation Hearing on April 30, 2025, supported by the Company\u2019s major stakeholders.\n<\/p>\n<p>\nUpon confirmation and effectiveness of the plan, Wellpath will formally complete its Chapter 11 process with a strengthened financial foundation and significantly less debt, which will position the Company for long-term success.\n<\/p>\n<p>\nMcDermott Will &amp; Emery is Wellpath\u2019s legal counsel, Lazard and MTS Health Partners are its investment bankers, and FTI Consulting is its restructuring advisor.\n<\/p>\n<p>\n<b>ABOUT WELLPATH<\/b>\n<\/p>\n<p>\nWellpath is the premier provider of quality, localized, patient-focused healthcare to local, state, and federal correctional facilities. We hold patients at the center of everything we do and promote rigorous standards of care and innovation. With an extensive network of more than 14,000 clinicians and professionals in thirty-seven states across the U.S., Wellpath provides medical and mental healthcare services to over 200,000 patients daily in more than 350 locations. Learn more about our comprehensive correctional healthcare solutions at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.wellpathcare.com%2F&amp;esheet=54238497&amp;newsitemid=20250415656984&amp;lan=en-US&amp;anchor=wellpathcare.com&amp;index=1&amp;md5=d2441a6fb48c216244f1d647efb43409\" rel=\"nofollow\" shape=\"rect\">wellpathcare.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media: <\/b>\n<\/p>\n<p>\nRachel Chesley \/ Rose Temple<br \/>\n<br \/>FTI Consulting<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#87;e&#x6c;&#108;p&#x61;&#116;h&#x43;&#x6f;m&#x6d;&#x73;&#64;&#x66;&#x74;&#105;&#x63;&#x6f;&#110;s&#x75;&#108;t&#x69;&#110;g&#x2e;&#99;o&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#x57;e&#x6c;&#108;p&#x61;&#116;&#x68;&#x43;o&#x6d;&#109;s&#x40;&#102;&#x74;&#105;c&#x6f;&#110;s&#x75;&#108;&#x74;&#105;n&#x67;&#46;&#x63;&#x6f;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Unsecured creditors encouraged to vote in favor of the Amended Plan Confirmation hearing scheduled for April 30 NASHVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;Wellpath and certain of its affiliates (\u201cWellpath\u201d or the \u201cCompany\u201d), the nation\u2019s leader in providing compassionate medical healthcare to vulnerable patients in challenging clinical environments, announced today that it has reached a global settlement with the &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61096","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Unsecured creditors encouraged to vote in favor of the Amended Plan Confirmation hearing scheduled for April 30 NASHVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;Wellpath and certain of its affiliates (\u201cWellpath\u201d or the \u201cCompany\u201d), the nation\u2019s leader in providing compassionate medical healthcare to vulnerable patients in challenging clinical environments, announced today that it has reached a global settlement with the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T17:05:12+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy\",\"datePublished\":\"2025-04-15T17:05:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/\"},\"wordCount\":443,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/\",\"name\":\"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2025-04-15T17:05:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/","og_locale":"en_US","og_type":"article","og_title":"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy - Pharma Trend","og_description":"Unsecured creditors encouraged to vote in favor of the Amended Plan Confirmation hearing scheduled for April 30 NASHVILLE, Tenn.&#8211;(BUSINESS WIRE)&#8211;Wellpath and certain of its affiliates (\u201cWellpath\u201d or the \u201cCompany\u201d), the nation\u2019s leader in providing compassionate medical healthcare to vulnerable patients in challenging clinical environments, announced today that it has reached a global settlement with the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/","og_site_name":"Pharma Trend","article_published_time":"2025-04-15T17:05:12+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy","datePublished":"2025-04-15T17:05:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/"},"wordCount":443,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/","url":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/","name":"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2025-04-15T17:05:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/wellpath-reaches-agreement-with-ucc-on-chapter-11-plan-and-swift-timeline-for-emergence-from-bankruptcy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Wellpath Reaches Agreement with UCC on Chapter 11 Plan and Swift Timeline for Emergence from Bankruptcy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61096"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61096\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}